Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

LON/HLN stock hub

LON/HLN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/HLNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

29.4B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/HLN

In the news

Latest news · LON/HLN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E16.1

P25 12.9P50 16.9P75 23.5

Trailing P/E17.9

P25 15.9P50 22.9P75 35.8

ROE10.3

P25 -54.2P50 2.1P75 13.7

ROIC8.2

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/HLN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

221

Groups with data

Currency

GBP

Showing 221 of 221 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	24,535
Employees Change	-26%
Employees Change Percent	-0.11
Enterprise value	GBX 36.8B
Exchange	London Stock Exchange
Financial currency	GBP
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	GB00BMX86B70
Last refreshed	2026-05-10
Market cap	GBX 29.4B
Price	GBX 331
Price currency	GBX
Rev Per Employee	449,561.85x
Sector	Healthcare
Sic	2834
Symbol	lon/HLN
Website	https://www.haleon.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.67%
EV Earnings	22.05x
EV/EBIT	14.68x
EV/EBITDA	13.15x
EV/FCF	15.9x
EV/Sales	3.33x
FCF yield	7.86%
Forward P/E	16.12x
P/B ratio	1.78x
P/E ratio	17.9x
P/S ratio	2.67x
PE Ratio3 Y	25.03x
PE Ratio5 Y	24.81x
PEG ratio	2.21x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	22.69%
EBITDA Margin	24.87%
FCF margin	20.96%
Gross margin	64.77%
Gross Profit	GBX 7.1B
Gross Profit Growth	0.58%
Gross Profit Growth Q	-0.14%
Gross Profit Growth3 Y	2.01%
Net Income	GBX 1.7B
Net Income Growth	15.6%
Net Income Growth Q	86.36%
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Net Income Growth3 Y	16.29%
Pretax Margin	19.51%
Profit Margin	15.11%
Profit Per Employee	GBX 67,944
Profitable Years	7
ROA	4.67
Roa5y	4.32
ROCE	9.04
ROE	10.27
Roe5y	7.32
ROIC	8.22
Roic5y	7.01

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-16.25%
Cagr3y	0.83%
Div CAGR3	19.13%
EPS Growth	17.83
EPS Growth Q	92.03
EPS Growth Quarters	1
EPS Growth Years	2
EPS Growth3 Y	17.25
FCF Growth	12.73%
FCF Growth3 Y	9.54%
OCF Growth	14.47%
OCF Growth3 Y	8.49%
Revenue Growth	-1.81x
Revenue Growth Q	0.58x
Revenue Growth Years	0x
Revenue Growth3 Y	0.53x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.33
Assets	GBX 32.6B
Cash	GBX 1.4B
Current Assets	GBX 4.6B
Current Liabilities	GBX 4.9B
Debt	GBX 8.6B
Debt EBITDA	GBX 3.09
Debt Equity	GBX 0.52
Debt FCF	GBX 3.73
Equity	GBX 16.5B
Interest Coverage	7.21
Liabilities	GBX 16.1B
Long Term Assets	GBX 28.1B
Long Term Liabilities	GBX 11.2B
Net Cash	GBX -7.3B
Net Cash By Market Cap	GBX -24.76
Net Debt EBITDA	GBX 2.66
Net Debt Equity	GBX 0.44
Net Debt FCF	GBX 3.15
Tangible Book Value	GBX -9.2B
Tangible Book Value Per Share	GBX -1.03
WACC	5.06

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.92
Inventory Turnover	3.51
Net Working Capital	GBX -896M
Quick ratio	0.68
Working Capital	GBX -383M
Working Capital Turnover	GBX -46.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.62%
Dividend Growth	7.58%
Dividend Growth Years	3%
Dividend per share	GBX 0.07
Dividend Years	4
Dividend Yield	2.14%
Ex Div Date	2026-04-09
Last Dividend	GBX 0.05
Payout Frequency	Semi-Annual
Payout Ratio	36.71%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-16.24%
200-day SMA	364.4
3Y total return	2.5%
50-day SMA	365.5
50-day SMA vs 200-day SMA	50over200
All Time High	419.5
All Time High Change	-21.05%
All Time High Date	2025-05-30
All Time Low	241.2
All Time Low Change	37.33%
All Time Low Date	2022-09-05
ATR	8.49
Beta	0.25
Beta1y	0.19
Beta2y	0.17
Ch YTD	-11.63
High	338.8
High52	419.5
High52 Date	2025-05-30
High52ch	-21.05%
Low	329.3
Low52	274.4
Low52 Date	2025-09-22
Low52ch	20.7%
Ma50ch	-9.39%
Price vs 200-day SMA	-9.11%
RSI	30.44
RSI Monthly	44.34
RSI Weekly	31.66
Sharpe ratio	-0.97x
Sortino ratio	-1.05
Total Return	3.77%
Tr YTD	-10.44
Tr1m	-9.08%
Tr1w	-3.75%
Tr3m	-15.68%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX 2.5B
Operating Income Growth	0.64
Operating Income Growth Q	1.9
Operating Income Growth3 Y	1.47
Operating margin	22.69

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	8,832,320,410%
Net Borrowing	-1,366,000,000
Shares Insiders	0.06%
Shares Institutions	93.88%
Shares Out	8,879,691,798
Shares Qo Q	0%
Shares Yo Y	-1.62%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX 2.2B
Average Volume	21,821,709.95x
Bv Per Share	1.84
CAPEX	GBX -322M
Ch1m	-10.29
Ch1w	-3.75
Ch1y	-17.86
Ch3m	-16.8
Ch3y	-3.02
Ch6m	-8.31
Change	-1.16%
Change From Open	-1.78
Close	335.1
Days Gap	0.63
Depreciation Amortization	240,000,000
Dollar Volume	10,902,538,641.6
Earnings Date	2026-07-30
EBIT	GBX 2.5B
EBITDA	GBX 2.7B
EPS	GBX 0.19
F Score	7
FCF	GBX 2.3B
FCF EV Yield	6.29x
FCF Per Share	GBX 0.26
Financing CF	-3,143,000,000
Fiscal Year End	December
Founded	1,715
Goodwill	8,127,000,000
Graham Number	280.022
Graham Upside	-15.45
Income Tax	GBX 472M
Investing CF	-346,000,000
Is Primary Listing	1
Last Earnings Date	2026-02-25
Last Report Date	2025-12-31
Lynch Fair Value	GBX 306
Lynch Upside	-7.66
Ma150	367.9
Ma150ch	-9.98%
Ma20	348.4
Ma20ch	-4.93%
Net CF	-904,000,000
Next Earnings Date	2026-07-30
Open	337.2
P FCF Ratio	12.72
P OCF Ratio	11.17
Payment Date	2026-05-14
Position In Range	20
Ppne	1,997,000,000
Price Date	2026-05-08
Price EBITDA	GBX 10.72
Relative Volume	1.57x
Revenue	11,030,000,000x
SBC By Revenue	0.78x
Share Based Comp	86,000,000
Tax By Revenue	4.28x
Tax Rate	21.93%
Tr6m	-7.07%
Volume	32,918,293
Z Score	3.02

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/HLN dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.1%

$0.07 annual per share

Payout ratio

+36.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

3 consecutive years of growth

Total shareholder yield

+3.8%

Next ex-dividend date: 2026-04-09

Performance

LON/HLN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/HLN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+93.9%

Share of float held by funds and institutions

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.6%

Negative means the company is buying back shares.

Technical

LON/HLN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

30.4

Neutral momentum band

Price vs 200-day MA

-9.1%

50/200-day relationship not available

Beta (5Y)

0.25

Less volatile than the market

Sharpe ratio

-0.97

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/HLN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/HLN stock rating?

lon/HLN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/HLN analysis?

The full report lives at /stocks/lon/HLN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/HLN?

The latest report frames lon/HLN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/HLN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.